0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Multigene Detection Kit Market Research Report 2023
Published Date: August 2023
|
Report Code: QYRE-Auto-4B15103
Home | Market Reports | Health| Health Conditions| Cancer
Global Tumor Multigene Detection Kit Market Research Report 2023
BUY CHAPTERS

Global Tumor Multigene Detection Kit Market Research Report 2023

Code: QYRE-Auto-4B15103
Report
August 2023
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tumor Multigene Detection Kit Market Size

According to QYResearch’s new survey, global Tumor Multigene Detection Kit market is projected to reach US$ 2477.8 million in 2029, increasing from US$ 877 million in 2022, with the CAGR of 16.0% during the period of 2023 to 2029.

Tumor Multigene Detection Kit Market

Tumor Multigene Detection Kit Market

Tumor NGS detection kit is an experimental consumable used in tumor detection
Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tumor Multigene Detection Kit market research.
Key manufacturers engaged in the Tumor Multigene Detection Kit industry include Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx and Burning Rock Medicine, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Tumor Multigene Detection Kit were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tumor Multigene Detection Kit market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tumor Multigene Detection Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Tumor Multigene Detection Kit Market Report

Report Metric Details
Report Name Tumor Multigene Detection Kit Market
Accounted market size in 2022 US$ 877 million
Forecasted market size in 2029 US$ 2477.8 million
CAGR 16.0%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Reversible End Termination Sequencing
  • Semiconductor Sequencing
  • Combined Probe Anchored Polymerization Sequencing
Segment by Application
  • Companion Diagnostics
  • Early Cancer Screening
  • Drug Discovery
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, NantHealth, Personal Genome Diagnostics, GTH.O
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Tumor Multigene Detection Kit Market market growing?

Ans: The Tumor Multigene Detection Kit Market market witnessing a CAGR of 16.0% during the forecast period 2023-2029.

What is the Tumor Multigene Detection Kit Market market size in 2029?

Ans: According to QYResearch’s new survey, global Tumor Multigene Detection Kit market is projected to reach US$ 2477.8 million in 2029, increasing from US$ 877 million in 2022, with the CAGR of 16.0% during the period of 2023 to 2029.

1 Tumor Multigene Detection Kit Market Overview
1.1 Product Overview and Scope of Tumor Multigene Detection Kit
1.2 Tumor Multigene Detection Kit Segment by Type
1.2.1 Global Tumor Multigene Detection Kit Market Value Comparison by Type (2023-2029)
1.2.2 Reversible End Termination Sequencing
1.2.3 Semiconductor Sequencing
1.2.4 Combined Probe Anchored Polymerization Sequencing
1.3 Tumor Multigene Detection Kit Segment by Application
1.3.1 Global Tumor Multigene Detection Kit Market Value by Application: (2023-2029)
1.3.2 Companion Diagnostics
1.3.3 Early Cancer Screening
1.3.4 Drug Discovery
1.3.5 Other
1.4 Global Tumor Multigene Detection Kit Market Size Estimates and Forecasts
1.4.1 Global Tumor Multigene Detection Kit Revenue 2018-2029
1.4.2 Global Tumor Multigene Detection Kit Sales 2018-2029
1.4.3 Global Tumor Multigene Detection Kit Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tumor Multigene Detection Kit Market Competition by Manufacturers
2.1 Global Tumor Multigene Detection Kit Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tumor Multigene Detection Kit Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tumor Multigene Detection Kit Average Price by Manufacturers (2018-2023)
2.4 Global Tumor Multigene Detection Kit Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tumor Multigene Detection Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Multigene Detection Kit, Product Type & Application
2.7 Tumor Multigene Detection Kit Market Competitive Situation and Trends
2.7.1 Tumor Multigene Detection Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tumor Multigene Detection Kit Players Market Share by Revenue
2.7.3 Global Tumor Multigene Detection Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tumor Multigene Detection Kit Retrospective Market Scenario by Region
3.1 Global Tumor Multigene Detection Kit Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tumor Multigene Detection Kit Global Tumor Multigene Detection Kit Sales by Region: 2018-2029
3.2.1 Global Tumor Multigene Detection Kit Sales by Region: 2018-2023
3.2.2 Global Tumor Multigene Detection Kit Sales by Region: 2024-2029
3.3 Global Tumor Multigene Detection Kit Global Tumor Multigene Detection Kit Revenue by Region: 2018-2029
3.3.1 Global Tumor Multigene Detection Kit Revenue by Region: 2018-2023
3.3.2 Global Tumor Multigene Detection Kit Revenue by Region: 2024-2029
3.4 North America Tumor Multigene Detection Kit Market Facts & Figures by Country
3.4.1 North America Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.4.3 North America Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Multigene Detection Kit Market Facts & Figures by Country
3.5.1 Europe Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.5.3 Europe Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Multigene Detection Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.6.3 Asia Pacific Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tumor Multigene Detection Kit Market Facts & Figures by Country
3.7.1 Latin America Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.7.3 Latin America Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tumor Multigene Detection Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Multigene Detection Kit Sales by Type (2018-2029)
4.1.1 Global Tumor Multigene Detection Kit Sales by Type (2018-2023)
4.1.2 Global Tumor Multigene Detection Kit Sales by Type (2024-2029)
4.1.3 Global Tumor Multigene Detection Kit Sales Market Share by Type (2018-2029)
4.2 Global Tumor Multigene Detection Kit Revenue by Type (2018-2029)
4.2.1 Global Tumor Multigene Detection Kit Revenue by Type (2018-2023)
4.2.2 Global Tumor Multigene Detection Kit Revenue by Type (2024-2029)
4.2.3 Global Tumor Multigene Detection Kit Revenue Market Share by Type (2018-2029)
4.3 Global Tumor Multigene Detection Kit Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tumor Multigene Detection Kit Sales by Application (2018-2029)
5.1.1 Global Tumor Multigene Detection Kit Sales by Application (2018-2023)
5.1.2 Global Tumor Multigene Detection Kit Sales by Application (2024-2029)
5.1.3 Global Tumor Multigene Detection Kit Sales Market Share by Application (2018-2029)
5.2 Global Tumor Multigene Detection Kit Revenue by Application (2018-2029)
5.2.1 Global Tumor Multigene Detection Kit Revenue by Application (2018-2023)
5.2.2 Global Tumor Multigene Detection Kit Revenue by Application (2024-2029)
5.2.3 Global Tumor Multigene Detection Kit Revenue Market Share by Application (2018-2029)
5.3 Global Tumor Multigene Detection Kit Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche Foundation Medicine
6.1.1 Roche Foundation Medicine Corporation Information
6.1.2 Roche Foundation Medicine Description and Business Overview
6.1.3 Roche Foundation Medicine Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolio
6.1.5 Roche Foundation Medicine Recent Developments/Updates
6.2 Illumina Inc.
6.2.1 Illumina Inc. Corporation Information
6.2.2 Illumina Inc. Description and Business Overview
6.2.3 Illumina Inc. Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Illumina Inc. Tumor Multigene Detection Kit Product Portfolio
6.2.5 Illumina Inc. Recent Developments/Updates
6.3 Life Technologies Corporation
6.3.1 Life Technologies Corporation Corporation Information
6.3.2 Life Technologies Corporation Description and Business Overview
6.3.3 Life Technologies Corporation Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolio
6.3.5 Life Technologies Corporation Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Memorial Sloan Kettering
6.5.1 Memorial Sloan Kettering Corporation Information
6.5.2 Memorial Sloan Kettering Description and Business Overview
6.5.3 Memorial Sloan Kettering Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolio
6.5.5 Memorial Sloan Kettering Recent Developments/Updates
6.6 Novogene
6.6.1 Novogene Corporation Information
6.6.2 Novogene Description and Business Overview
6.6.3 Novogene Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novogene Tumor Multigene Detection Kit Product Portfolio
6.6.5 Novogene Recent Developments/Updates
6.7 Geneseeq
6.6.1 Geneseeq Corporation Information
6.6.2 Geneseeq Description and Business Overview
6.6.3 Geneseeq Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Geneseeq Tumor Multigene Detection Kit Product Portfolio
6.7.5 Geneseeq Recent Developments/Updates
6.8 AmoyDx
6.8.1 AmoyDx Corporation Information
6.8.2 AmoyDx Description and Business Overview
6.8.3 AmoyDx Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AmoyDx Tumor Multigene Detection Kit Product Portfolio
6.8.5 AmoyDx Recent Developments/Updates
6.9 Burning Rock Medicine
6.9.1 Burning Rock Medicine Corporation Information
6.9.2 Burning Rock Medicine Description and Business Overview
6.9.3 Burning Rock Medicine Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolio
6.9.5 Burning Rock Medicine Recent Developments/Updates
6.10 NantHealth
6.10.1 NantHealth Corporation Information
6.10.2 NantHealth Description and Business Overview
6.10.3 NantHealth Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.10.4 NantHealth Tumor Multigene Detection Kit Product Portfolio
6.10.5 NantHealth Recent Developments/Updates
6.11 Personal Genome Diagnostics
6.11.1 Personal Genome Diagnostics Corporation Information
6.11.2 Personal Genome Diagnostics Tumor Multigene Detection Kit Description and Business Overview
6.11.3 Personal Genome Diagnostics Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolio
6.11.5 Personal Genome Diagnostics Recent Developments/Updates
6.12 GTH.O
6.12.1 GTH.O Corporation Information
6.12.2 GTH.O Tumor Multigene Detection Kit Description and Business Overview
6.12.3 GTH.O Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.12.4 GTH.O Tumor Multigene Detection Kit Product Portfolio
6.12.5 GTH.O Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Multigene Detection Kit Industry Chain Analysis
7.2 Tumor Multigene Detection Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Multigene Detection Kit Production Mode & Process
7.4 Tumor Multigene Detection Kit Sales and Marketing
7.4.1 Tumor Multigene Detection Kit Sales Channels
7.4.2 Tumor Multigene Detection Kit Distributors
7.5 Tumor Multigene Detection Kit Customers
8 Tumor Multigene Detection Kit Market Dynamics
8.1 Tumor Multigene Detection Kit Industry Trends
8.2 Tumor Multigene Detection Kit Market Drivers
8.3 Tumor Multigene Detection Kit Market Challenges
8.4 Tumor Multigene Detection Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Tumor Multigene Detection Kit Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Tumor Multigene Detection Kit Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Tumor Multigene Detection Kit Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Tumor Multigene Detection Kit Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Tumor Multigene Detection Kit Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Tumor Multigene Detection Kit Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Tumor Multigene Detection Kit Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Tumor Multigene Detection Kit, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Tumor Multigene Detection Kit, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Tumor Multigene Detection Kit, Product Type & Application
    Table 12. Global Key Manufacturers of Tumor Multigene Detection Kit, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Tumor Multigene Detection Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Multigene Detection Kit as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Tumor Multigene Detection Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Tumor Multigene Detection Kit Sales by Region (2018-2023) & (K Units)
    Table 18. Global Tumor Multigene Detection Kit Sales Market Share by Region (2018-2023)
    Table 19. Global Tumor Multigene Detection Kit Sales by Region (2024-2029) & (K Units)
    Table 20. Global Tumor Multigene Detection Kit Sales Market Share by Region (2024-2029)
    Table 21. Global Tumor Multigene Detection Kit Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Tumor Multigene Detection Kit Revenue Market Share by Region (2018-2023)
    Table 23. Global Tumor Multigene Detection Kit Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Tumor Multigene Detection Kit Revenue Market Share by Region (2024-2029)
    Table 25. North America Tumor Multigene Detection Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
    Table 27. North America Tumor Multigene Detection Kit Sales by Country (2024-2029) & (K Units)
    Table 28. North America Tumor Multigene Detection Kit Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Tumor Multigene Detection Kit Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Tumor Multigene Detection Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Tumor Multigene Detection Kit Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Tumor Multigene Detection Kit Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Tumor Multigene Detection Kit Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Tumor Multigene Detection Kit Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Tumor Multigene Detection Kit Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Tumor Multigene Detection Kit Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Tumor Multigene Detection Kit Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Tumor Multigene Detection Kit Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Tumor Multigene Detection Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Tumor Multigene Detection Kit Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Tumor Multigene Detection Kit Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Tumor Multigene Detection Kit Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Tumor Multigene Detection Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Tumor Multigene Detection Kit Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Tumor Multigene Detection Kit Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Tumor Multigene Detection Kit Sales (K Units) by Type (2018-2023)
    Table 51. Global Tumor Multigene Detection Kit Sales (K Units) by Type (2024-2029)
    Table 52. Global Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
    Table 53. Global Tumor Multigene Detection Kit Sales Market Share by Type (2024-2029)
    Table 54. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2018-2023)
    Table 57. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2024-2029)
    Table 58. Global Tumor Multigene Detection Kit Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Tumor Multigene Detection Kit Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Tumor Multigene Detection Kit Sales (K Units) by Application (2018-2023)
    Table 61. Global Tumor Multigene Detection Kit Sales (K Units) by Application (2024-2029)
    Table 62. Global Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
    Table 63. Global Tumor Multigene Detection Kit Sales Market Share by Application (2024-2029)
    Table 64. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Tumor Multigene Detection Kit Revenue Market Share by Application (2018-2023)
    Table 67. Global Tumor Multigene Detection Kit Revenue Market Share by Application (2024-2029)
    Table 68. Global Tumor Multigene Detection Kit Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Tumor Multigene Detection Kit Price (US$/Unit) by Application (2024-2029)
    Table 70. Roche Foundation Medicine Corporation Information
    Table 71. Roche Foundation Medicine Description and Business Overview
    Table 72. Roche Foundation Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. Roche Foundation Medicine Tumor Multigene Detection Kit Product
    Table 74. Roche Foundation Medicine Recent Developments/Updates
    Table 75. Illumina Inc. Corporation Information
    Table 76. Illumina Inc. Description and Business Overview
    Table 77. Illumina Inc. Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. Illumina Inc. Tumor Multigene Detection Kit Product
    Table 79. Illumina Inc. Recent Developments/Updates
    Table 80. Life Technologies Corporation Corporation Information
    Table 81. Life Technologies Corporation Description and Business Overview
    Table 82. Life Technologies Corporation Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Life Technologies Corporation Tumor Multigene Detection Kit Product
    Table 84. Life Technologies Corporation Recent Developments/Updates
    Table 85. Thermo Fisher Scientific Corporation Information
    Table 86. Thermo Fisher Scientific Description and Business Overview
    Table 87. Thermo Fisher Scientific Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Thermo Fisher Scientific Tumor Multigene Detection Kit Product
    Table 89. Thermo Fisher Scientific Recent Developments/Updates
    Table 90. Memorial Sloan Kettering Corporation Information
    Table 91. Memorial Sloan Kettering Description and Business Overview
    Table 92. Memorial Sloan Kettering Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Memorial Sloan Kettering Tumor Multigene Detection Kit Product
    Table 94. Memorial Sloan Kettering Recent Developments/Updates
    Table 95. Novogene Corporation Information
    Table 96. Novogene Description and Business Overview
    Table 97. Novogene Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Novogene Tumor Multigene Detection Kit Product
    Table 99. Novogene Recent Developments/Updates
    Table 100. Geneseeq Corporation Information
    Table 101. Geneseeq Description and Business Overview
    Table 102. Geneseeq Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. Geneseeq Tumor Multigene Detection Kit Product
    Table 104. Geneseeq Recent Developments/Updates
    Table 105. AmoyDx Corporation Information
    Table 106. AmoyDx Description and Business Overview
    Table 107. AmoyDx Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. AmoyDx Tumor Multigene Detection Kit Product
    Table 109. AmoyDx Recent Developments/Updates
    Table 110. Burning Rock Medicine Corporation Information
    Table 111. Burning Rock Medicine Description and Business Overview
    Table 112. Burning Rock Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. Burning Rock Medicine Tumor Multigene Detection Kit Product
    Table 114. Burning Rock Medicine Recent Developments/Updates
    Table 115. NantHealth Corporation Information
    Table 116. NantHealth Description and Business Overview
    Table 117. NantHealth Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. NantHealth Tumor Multigene Detection Kit Product
    Table 119. NantHealth Recent Developments/Updates
    Table 120. Personal Genome Diagnostics Corporation Information
    Table 121. Personal Genome Diagnostics Description and Business Overview
    Table 122. Personal Genome Diagnostics Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. Personal Genome Diagnostics Tumor Multigene Detection Kit Product
    Table 124. Personal Genome Diagnostics Recent Developments/Updates
    Table 125. GTH.O Corporation Information
    Table 126. GTH.O Description and Business Overview
    Table 127. GTH.O Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 128. GTH.O Tumor Multigene Detection Kit Product
    Table 129. GTH.O Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Tumor Multigene Detection Kit Distributors List
    Table 133. Tumor Multigene Detection Kit Customers List
    Table 134. Tumor Multigene Detection Kit Market Trends
    Table 135. Tumor Multigene Detection Kit Market Drivers
    Table 136. Tumor Multigene Detection Kit Market Challenges
    Table 137. Tumor Multigene Detection Kit Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Tumor Multigene Detection Kit
    Figure 2. Global Tumor Multigene Detection Kit Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Tumor Multigene Detection Kit Market Share by Type in 2022 & 2029
    Figure 4. Reversible End Termination Sequencing Product Picture
    Figure 5. Semiconductor Sequencing Product Picture
    Figure 6. Combined Probe Anchored Polymerization Sequencing Product Picture
    Figure 7. Global Tumor Multigene Detection Kit Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Tumor Multigene Detection Kit Market Share by Application in 2022 & 2029
    Figure 9. Companion Diagnostics
    Figure 10. Early Cancer Screening
    Figure 11. Drug Discovery
    Figure 12. Other
    Figure 13. Global Tumor Multigene Detection Kit Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Tumor Multigene Detection Kit Market Size (2018-2029) & (US$ Million)
    Figure 15. Global Tumor Multigene Detection Kit Sales (2018-2029) & (K Units)
    Figure 16. Global Tumor Multigene Detection Kit Average Price (US$/Unit) & (2018-2029)
    Figure 17. Tumor Multigene Detection Kit Report Years Considered
    Figure 18. Tumor Multigene Detection Kit Sales Share by Manufacturers in 2022
    Figure 19. Global Tumor Multigene Detection Kit Revenue Share by Manufacturers in 2022
    Figure 20. The Global 5 and 10 Largest Tumor Multigene Detection Kit Players: Market Share by Revenue in 2022
    Figure 21. Tumor Multigene Detection Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 22. Global Tumor Multigene Detection Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 23. North America Tumor Multigene Detection Kit Sales Market Share by Country (2018-2029)
    Figure 24. North America Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2029)
    Figure 25. United States Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Canada Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Europe Tumor Multigene Detection Kit Sales Market Share by Country (2018-2029)
    Figure 28. Europe Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2029)
    Figure 29. Germany Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. France Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. U.K. Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Italy Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Russia Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Asia Pacific Tumor Multigene Detection Kit Sales Market Share by Region (2018-2029)
    Figure 35. Asia Pacific Tumor Multigene Detection Kit Revenue Market Share by Region (2018-2029)
    Figure 36. China Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Japan Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. South Korea Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. India Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Australia Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. China Taiwan Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Southeast Asia Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Latin America Tumor Multigene Detection Kit Sales Market Share by Country (2018-2029)
    Figure 44. Latin America Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2029)
    Figure 45. Mexico Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Brazil Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Argentina Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Colombia Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Country (2018-2029)
    Figure 50. Middle East & Africa Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2029)
    Figure 51. Turkey Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. UAE Tumor Multigene Detection Kit Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Global Sales Market Share of Tumor Multigene Detection Kit by Type (2018-2029)
    Figure 55. Global Revenue Market Share of Tumor Multigene Detection Kit by Type (2018-2029)
    Figure 56. Global Tumor Multigene Detection Kit Price (US$/Unit) by Type (2018-2029)
    Figure 57. Global Sales Market Share of Tumor Multigene Detection Kit by Application (2018-2029)
    Figure 58. Global Revenue Market Share of Tumor Multigene Detection Kit by Application (2018-2029)
    Figure 59. Global Tumor Multigene Detection Kit Price (US$/Unit) by Application (2018-2029)
    Figure 60. Tumor Multigene Detection Kit Value Chain
    Figure 61. Tumor Multigene Detection Kit Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Immunotherapy Drugs for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39R14639
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cancer Early Detection and Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37I14671
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global One-Stop Radiotherapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33G18542
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-1A14903
Thu Dec 12 00:00:00 UTC 2024

Add to Cart